Amsterdam UMC at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Amsterdam UMC takes part in 8 sessions at CTAD 2026 in Boston. Its program centres on amyloid and tau PET staging and on making preclinical anti-amyloid trials easier to recruit. Its work covers brain delivery of trontinemab, community-based screening and outcome measures for everyday function.
| Organization | CTAD 2026 Attendance |
|---|---|
Amsterdam UMC Amsterdam, Netherlands | |
University medical centre whose Alzheimer Center Amsterdam runs memory-clinic cohorts, biomarker and PET research and dementia trials. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Talk Mon Nov 16 4:50pm–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Amsterdam UMC
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction